Home › Stargardt Disease › Maryland › Baltimore
Stargardt Disease clinical trials in Baltimore, MD
3 studies for Stargardt Disease are looking for participants at sites in and around Baltimore (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)
RecruitingObservational study
- Wilmer Eye Institute at John Hopkins, Baltimore
Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)
RecruitingPhase 1/2
- Wilmer Eye Institute at John Hopkins, Baltimore
An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene
RecruitingObservational study
- Wilmer Eye Institute, Johns Hopkins University MD 21287, Baltimore
Stargardt Disease trials in other cities
- Dallas, TX9 studies
- Boston, MA5 studies
- Phoenix, AZ4 studies
- Houston, TX4 studies
- Cincinnati, OH4 studies
- Ann Arbor, MI4 studies
- Gainesville, FL4 studies
- Miami, FL4 studies
- Portland, OR4 studies
- Pittsburgh, PA3 studies
- Aurora, CO3 studies
Other studies in Baltimore
- Non-Small Cell Lung Cancer60 studies
- Breast Cancer47 studies
- Prostate Cancer43 studies
- Lung Cancer40 studies
- Cancer (all types)37 studies
- Colorectal Cancer31 studies
- Pancreatic Cancer31 studies
- Metastatic Cancer28 studies
- Obesity25 studies
- Heart Failure24 studies
- Bladder Cancer24 studies
- Stroke22 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.